Search Results - "RIDER, M. H"

Refine Results
  1. 1

    AMPK antagonizes hepatic glucagon-stimulated cyclic AMP signalling via phosphorylation-induced activation of cyclic nucleotide phosphodiesterase 4B by Johanns, M., Lai, Y.-C., Hsu, M.-F., Jacobs, R., Vertommen, D., Van Sande, J., Dumont, J. E., Woods, A., Carling, D., Hue, L., Viollet, B., Foretz, M, Rider, M H

    Published in Nature communications (08-03-2016)
    “…Biguanides such as metformin have previously been shown to antagonize hepatic glucagon-stimulated cyclic AMP (cAMP) signalling independently of AMP-activated…”
    Get full text
    Journal Article
  2. 2

    Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia by Marsin, A-S., Bertrand†, L., Rider, M.H., Deprez, J., Beauloye, C., Vincent‡, M.F., Van den Berghe‡, G., Carling, D., Hue, L.

    Published in Current biology (19-10-2000)
    “…Background: The role of protein phosphorylation in the Pasteur effect—the phenomenon whereby anaerobic conditions stimulate glycolysis—has not been addressed…”
    Get full text
    Journal Article
  3. 3

    Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase by DELPIERRE, Ghislain, RIDER, Mark H, COLLARD, Francois, STROOBANT, Vincent, VANSTAPEL, Florent, SANTOS, Helena, VAN SCHAFTINGEN, Emile

    Published in Diabetes (New York, N.Y.) (01-10-2000)
    “…Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. G Delpierre , M H Rider , F Collard , V Stroobant , F Vanstapel , H…”
    Get full text
    Journal Article
  4. 4

    6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells by Ros, S, Flöter, J, Kaymak, I, Da Costa, C, Houddane, A, Dubuis, S, Griffiths, B, Mitter, R, Walz, S, Blake, S, Behrens, A, Brindle, K M, Zamboni, N, Rider, M H, Schulze, A

    Published in Oncogene (08-06-2017)
    “…The bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 (PFKFB4) controls metabolic flux through allosteric regulation of glycolysis…”
    Get full text
    Journal Article
  5. 5

    Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase by Johanns, M., Pyr dit Ruys, S., Houddane, A., Vertommen, D., Herinckx, G., Hue, L., Proud, C.G., Rider, M.H.

    Published in Cellular signalling (01-08-2017)
    “…Eukaryotic elongation factor 2 (eEF2) kinase (eEF2K) is a key regulator of protein synthesis in mammalian cells. It phosphorylates and inhibits eEF2, the…”
    Get full text
    Journal Article
  6. 6

    Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues by Hue, L, Rider, M H

    Published in Biochemical journal (15-07-1987)
    “…Since Fru-2,6-P sub(2) is present in all mammalian tissues, it is tempting to suppose that it plays the major role in the control of glycolysis. The purpose of…”
    Get full text
    Journal Article
  7. 7

    New targets of AMP-activated protein kinase by Hue, L, Beauloye, C, Bertrand, L, Horman, S, Krause, U, Marsin, A-S, Meisse, D, Vertommen, D, Rider, M H

    Published in Biochemical Society transactions (01-02-2003)
    “…The discovery of the AMP-activated protein kinase (AMPK) more than a decade ago has shed much light on the cellular response to stresses characterized by a…”
    Get more information
    Journal Article
  8. 8

    Regulation of oxidative enzyme activity and eukaryotic elongation factor 2 in human skeletal muscle: influence of gender and exercise by Roepstorff, C., Schjerling, P., Vistisen, B., Madsen, M., Steffensen, C. H., Rider, M. H., Kiens, B.

    Published in Acta physiologica Scandinavica (01-07-2005)
    “…Aim:  To investigate gender‐related differences in the responses of oxidative enzymes and eukaryotic elongation factor‐2 (eEF2) to exercise. Methods:  The…”
    Get full text
    Journal Article
  9. 9

    Identification of Phosphorylation Sites on Human Deoxycytidine Kinase After Overexpression in Eucaryotic Cells by Smal, C., Vertommen, D., Bertrand, L., Rider, M. H., Van Den Neste, E., Bontemps, F.

    Published in Nucleosides, nucleotides & nucleic acids (01-06-2006)
    “…Compelling evidence suggests that deoxycytidine kinase (dCK), a key enzyme in the salvage of deoxyribonucleosides and in the activation of clinically relevant…”
    Get full text
    Journal Article
  10. 10

    Role of fructose 2,6-bisphosphate in the control of heart glycolysis by DEPRE, C, RIDER, M. H, VEITCH, K, HUE, L

    Published in The Journal of biological chemistry (25-06-1993)
    “…The aim of this work was to study whether changes in fructose 2,6-bisphosphate concentration are correlated with variations of the glycolytic flux in the…”
    Get full text
    Journal Article
  11. 11

    Myocardial Ischemia and Increased Heart Work Modulate the Phosphorylation State of Eukaryotic Elongation Factor-2 by Horman, Sandrine, Beauloye, Christophe, Vertommen, Didier, Vanoverschelde, Jean-Louis, Hue, Louis, Rider, Mark H.

    Published in The Journal of biological chemistry (24-10-2003)
    “…Protein synthesis, in particular peptide chain elongation, is an energy-consuming biosynthetic process. AMP-activated protein kinase (AMPK) is a key regulatory…”
    Get full text
    Journal Article
  12. 12

    Phosphorylation and Activation of Heart 6-Phosphofructo-2-kinase by Protein Kinase B and Other Protein Kinases of the Insulin Signaling Cascades by Deprez, Johan, Vertommen, Didier, Alessi, Dario R., Hue, Louis, Rider, Mark H.

    Published in The Journal of biological chemistry (11-07-1997)
    “…To understand the insulin-induced activation of 6-phosphofructo-2-kinase (PFK-2) of the bifunctional enzyme PFK-2/fructose-2,6-bisphosphatase in heart, the…”
    Get full text
    Journal Article
  13. 13

    Inhibition of Spliceosome Assembly by the Cell Cycle-regulated Protein Kinase MELK and Involvement of Splicing Factor NIPP1 by Vulsteke, Veerle, Beullens, Monique, Boudrez, An, Keppens, Stefaan, Van Eynde, Aleyde, Rider, Mark H., Stalmans, Willy, Bollen, Mathieu

    Published in The Journal of biological chemistry (05-03-2004)
    “…NIPP1 is a ubiquitous nuclear protein that is required for spliceosome assembly. We report here that the phosphothreonine-binding Forkhead-associated domain of…”
    Get full text
    Journal Article
  14. 14

    Palmitate inhibits liver glycolysis. Involvement of fructose 2,6-bisphosphate in the glucose/fatty acid cycle by Hue, L, Maisin, L, Rider, M H

    Published in Biochemical journal (15-04-1988)
    “…In hepatocytes from overnight-fasted rats incubated with glucose, palmitate decreased the production of lactate, the detritiation of [2-3H]- and…”
    Get full text
    Journal Article
  15. 15

    Site-directed mutagenesis of rat muscle 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase : role of Asp-130 in the 2-kinase domain by RIDER, M. H, CREPIN, K. M, DE CLOEDT, M, BERTRAND, L, HUE, L

    Published in Biochemical journal (15-05-1994)
    “…Asp-130 of the recombinant skeletal-muscle 6-phosphofructo-2-kinase (PFK-2)/fructose-2,6-bisphosphatase was mutated into Ala in order to study its role in…”
    Get full text
    Journal Article
  16. 16

    Complete nucleotide sequence coding for rat liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase derived from a cDNA clone by Darville, M.I., Crepin, K.M., Vandekerckhove, J., Van Damme, J., Octave, J.N., Rider, M.H., Marchand, M.J., Hue, L., Rousseau, G.G.

    Published in FEBS letters (30-11-1987)
    “…cDNA clones for 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase were isolated from rat liver expression libraries in λgt11 by antibody, oligonucleotide,…”
    Get full text
    Journal Article
  17. 17

    Molecular forms of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase expressed in rat skeletal muscle by Crepin, K.M., De Cloedt, M, Vertommen, D, Foret, D, Michel, A, Rider, M.H., Rousseau, G.G., Hue, L

    Published in The Journal of biological chemistry (25-10-1992)
    “…The rat cDNA for the muscle-type (M) isozyme of 6-phosphofructo-2-kinase (PFK-2)/fructose-2,6-bisphosphatase (FBPase-2) contains two putative translation…”
    Get full text
    Journal Article
  18. 18

    Rat muscle 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Study of the kinase domain by site-directed mutagenesis by CREPIN, K. M, VERTOMMEN, D, DOM, G, HUE, L, RIDER, M. H

    Published in The Journal of biological chemistry (15-07-1993)
    “…Sequence alignment and modeling of the 2-kinase domain of the liver bifunctional enzyme, 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase, on…”
    Get full text
    Journal Article
  19. 19

    6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase from frog skeletal muscle : purification, kinetics and immunological properties by PYKO, M, RIDER, M. H, WEGENER, G

    “…Fructose 2,6-bisphosphate is the most potent activator of 6-phosphofructo-1-kinase, a key regulatory enzyme of glycolysis in animal tissues. This study was…”
    Get full text
    Journal Article
  20. 20

    The two forms of bovine heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase result from alternative splicing by RIDER, M. H, VANDAMME, J, LEBEAU, E, VERTOMMEN, D, VIDAL, H, ROUSSEAU, G. G, VANDEKERCKHOVE, J, HUE, L

    Published in Biochemical journal (15-07-1992)
    “…Purified bovine heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2) showed two bands with subunit M(r) of 58,000 and 54,000 when…”
    Get full text
    Journal Article